MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research -
Share

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment

You might also be interested in ...

See all articles

press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
Research
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
Web Training HIRO TT - Thailand
News - 26/10/2020
Implemented in collaboration with IMS (ASA’s distributor for Thailand), the meeting was attended by a total of 70 doctors and physiotherapists, 30 in the conference room of the Bangkok Hospital, the...
Taipei: Mphi 75 ASA devices for charity
News - 23/10/2020
Two Mphi 75 devices were used by doctors and physiotherapists from the Lovelis Pain Management Clinic in Taipei for a free of charge treatment of 44 elderly people from the town of Fuli, which has no...
Soccer Club FK Austria Wien
News - 22/10/2020
The excellence of MLS® and Hilterapia® in the treatment of pathologies linked to carrying out both professional and amateur physical activity was highlighted during the meeting “Treatments in Sport”...